![](/img/cover-not-exists.png)
Rationale and design of the randomized, multicenter, open-label, controlled POLBOS 3 trial aimed to compare regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM C stent
Gil, Robert J., Pawłowski, Tomasz, Legutko, Jacek, Lesiak, Maciej, Witkowski, Adam, Gąsior, Mariusz, Kern, Adam, Bil, JacekVolume:
98
Journal:
Medicine
DOI:
10.1097/md.0000000000015106
Date:
April, 2019
File:
PDF, 214 KB
2019